मायस्थेनिया ग्रेविस
अंतिम अद्यतन 5 नवम्बर 2021
मरीज की संपादकीय दिशानिर्देशों
- डाउनलोडडाउनलोड
- साझा करें
- Language
- चर्चा
- Ask Patient
- ऑडियो संस्करण
- Google पर पसंदीदा स्रोतों में जोड़ें
Myasthenia gravis is a disorder that causes weakness of the skeletal muscles, which are muscles that the body uses for movement. The weakness most often starts in the muscles around the eyes, causing drooping of the eyelids (ptosis) and difficulty coordinating eye movements, which results in blurred or double vision. In a form of the disorder called ocular myasthenia, the weakness remains confined to the eye muscles. In most people with myasthenia gravis, however, additional muscles in the face and neck are affected. Affected individuals may have unusual facial expressions, difficulty holding up the head, speech impairment (dysarthria), and chewing and swallowing problems (dysphagia) that may lead to choking, gagging, or drooling.
के लिए वीडियो चयन आनुवंशिक स्थितियाँवीडियो लाइब्रेरी
विवरण
Myasthenia gravis is a disorder that causes weakness of the skeletal muscles, which are muscles that the body uses for movement. The weakness most often starts in the muscles around the eyes, causing drooping of the eyelids (ptosis) and difficulty coordinating eye movements, which results in blurred or double vision. In a form of the disorder called ocular myasthenia, the weakness remains confined to the eye muscles. In most people with myasthenia gravis, however, additional muscles in the face and neck are affected. Affected individuals may have unusual facial expressions, difficulty holding up the head, speech impairment (dysarthria), and chewing and swallowing problems (dysphagia) that may lead to choking, gagging, or drooling.
Other muscles in the body are also affected in some people with myasthenia gravis. The muscles of the arms and legs may be involved, causing affected individuals to have changes in their gait or trouble with lifting objects, rising from a seated position, or climbing stairs. The muscle weakness tends to fluctuate over time; it typically worsens with activity and improves with rest.
Weakness of the muscles in the chest wall and the muscle that separates the abdomen from the chest cavity (the diaphragm) can cause breathing problems in some people with myasthenia gravis. About 10 percent of people with this disorder experience a potentially life-threatening complication in which these respiratory muscles weaken to the point that breathing is dangerously impaired, and the affected individual requires ventilation assistance. This respiratory failure, called a myasthenic crisis, may be triggered by stresses such as infections or reactions to medications.
People can develop myasthenia gravis at any age. For reasons that are unknown, it is most commonly diagnosed in women younger than age 40 and men older than age 60. It is uncommon in children, but some infants born to women with myasthenia gravis show signs and symptoms of the disorder for the first few days or weeks of life. This temporary occurrence of symptoms is called transient neonatal myasthenia gravis.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Other names
MG
Related patient information and medicines

Patient information leaflet
मायस्थेनिया ग्रेविस
Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. यह है due को a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune.

Medicine leaflet
मायस्थेनिया ग्रेविस के लिए पायरिडोस्टिग्माइन
Doses vary from person to person so it is important that you take pyridostigmine tablets exactly as you are directed by your doctor. Take your ... About pyridostigmine Type of medicine An anticholinesterase Used for मायस्थेनिया ग्रेविस Also called Mestinon® Available as Tablets Myasthenia gravis Myasthenia gravis is a condition where your muscles.

Medicine leaflet
मायस्थेनिया ग्रेविस के लिए नियोस्टिग्मिन
If you are unsure about how to take any of your medicines, ask your doctor or pharmacist for advice. About neostigmine Type of medicine An anticholinesterase के लिए उपयोग किया जाता है मायस्थेनिया ग्रेविस Available as Tablets (discontinued), injections or special order liquid medicines Myasthenia gravis Myasthenia gravis is a condition where your muscles become.

Patient information leaflet
मांसपेशियों की कमजोरी
Muscle tiredness This is sometimes called asthenia. This often goes along with muscle tiredness but is also particularly seen in some uncommon conditions such as myasthenia gravis Myasthenia gravis and myotonic dystrophy. Myotonic dystrophy : This is a rare genetic muscle disorder in which muscles become extremely tired. Myotonic dystrophies are.

Patient information leaflet
आंखों की समस्याएं
This leaflet contains a list of conditions which affect the eye, grouped together by the part of the eye which is affected or involved. Retinal dystrophy Retinal dystrophies are a group of inherited disorders which result in changes to the retina, which may affect vision; some people with this con... Less common causes of ptosis include diseases.

Patient information leaflet
क्या मैं ज़ोपिक्लोन और शराब को एक साथ ले सकता हूँ?
Do not drive or operate machinery for at least 12 hours after taking your dose, even if you feel awake, as your coordination and reaction times will be s... मायस्थेनिया ग्रेविस or severe respiratory failure Do not take zopiclone if you have myasthenia gravis or severe breathing problems (such as severe COPD or sleep apnoea), as the medicine can.
अधिक पठन और संदर्भ
- मायस्थेनिया ग्रेविस; MedlinePlus, National Library of Medicine.
- Angelini C. Diagnosis and management of autoimmune myasthenia gravis. Clin Drug Investig. 2011;31(1):1-14. doi: 10.2165/11584740-000000000-00000.
- Avidan N, Le Panse R, Berrih-Aknin S, Miller A. Genetic basis of myasthenia gravis - a comprehensive review. J Autoimmun. 2014 Aug;52:146-53. doi: 10.1016/j.jaut.2013.12.001. Epub 2013 Dec 19.
- Berrih-Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun. 2014 Aug;52:90-100. doi: 10.1016/j.jaut.2013.12.011. Epub 2014 Jan 3.
- Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010 Jun 18;10:46. doi: 10.1186/1471-2377-10-46.
- Ha JC, Richman DP. Myasthenia gravis and related disorders: Pathology and molecular pathogenesis. Biochim Biophys Acta. 2015 Apr;1852(4):651-7. doi: 10.1016/j.bbadis.2014.11.022. Epub 2014 Dec 6.
- Mao ZF, Mo XA, Qin C, Lai YR, Olde Hartman TC. Course and prognosis of myasthenia gravis: a systematic review. Eur J Neurol. 2010 Jul;17(7):913-21. doi: 10.1111/j.1468-1331.2010.03017.x. Epub 2010 Apr 12.
- Pal J, Rozsa C, Komoly S, Illes Z. Clinical and biological heterogeneity of autoimmune myasthenia gravis. J Neuroimmunol. 2011 Feb;231(1-2):43-54. doi: 10.1016/j.jneuroim.2010.10.020. Epub 2010 Nov 19.
- Sieb JP. Myasthenia gravis: an update for the clinician. Clin Exp Immunol. 2014 Mar;175(3):408-18. doi: 10.1111/cei.12217.
- Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D. Myasthenia gravis: Association of British Neurologists' management guidelines. Pract Neurol. 2015 Jun;15(3):199-206. doi: 10.1136/practneurol-2015-001126.
- Zagoriti Z, Kambouris ME, Patrinos GP, Tzartos SJ, Poulas K. Recent advances in genetic predisposition of myasthenia gravis. Biomed Res Int. 2013;2013:404053. doi: 10.1155/2013/404053. Epub 2013 Nov 5.
हमारे में दूसरों के साथ अपने विचार या अनुभव साझा करें रोगी समुदायों.
पेशेंट न्यूज़लेटर के लिए साइन अप करें
आपकी साप्ताहिक खुराक स्पष्ट, विश्वसनीय स्वास्थ्य सलाह की - जो आपको सूचित, आत्मविश्वासी और नियंत्रण में महसूस करने में मदद करने के लिए लिखी गई है।.
सदस्यता लेने पर आप हमारी स्वीकार करते हैं गोपनीयता नीति. आप किसी भी समय सदस्यता समाप्त कर सकते हैं। हम कभी भी आपका डेटा नहीं बेचते।.

